Efficacy and Safety of Triazavirin Therapy for Coronavirus Disease 2019: A Pilot Randomized Controlled Trial

Xiaoke Wu(First Affiliated Hospital of Heilongjiang University of Chinese Medicine), Baofeng Yang(Harbin Medical University), Kaijiang Yu(Harbin Medical University), Jingshu Gao(First Affiliated Hospital of Heilongjiang University of Chinese Medicine), Huichao Qin(First Affiliated Hospital of Heilongjiang University of Chinese Medicine), Lu Li(California University of Pennsylvania), Benzhi Cai(Second Affiliated Hospital of Harbin Medical University), Ben W. Mol(Radboud University Nijmegen), Wenjie Wang(Harbin Medical University), Yue Li(Heilongjiang Academy of Sciences), Min Zhang(Heilongjiang Provincial Hospital), Yu Wang(China Medical University), Kang Li(Harbin Medical University), Yong Zhang(Guangxi Medical University), Xiaoli Hu(Shandong Eye Hospital), Xia Wu(First Affiliated Hospital of Heilongjiang University of Chinese Medicine), Yongchen Wang(Harbin Medical University), Mingyan Zhao(Harbin Medical University), Zhimin Du(Harbin Medical University), Lìyǐng Zhū(Fourth Affiliated Hospital of Harbin Medical University), Wanhai Xu(Harbin Medical University), Hongli Ma(First Affiliated Hospital of Heilongjiang University of Chinese Medicine), Yan Hou(Harbin Medical University)
Engineering
September 7, 2020
Cited by 59


Related Papers